Thomas Middelhoff News
-
Arcandor AG’s insolvency administrator won a German ruling holding former Chief Executive Officer Thomas Middelhoff and other former management board members liable for management failures.
-
Bertelsmann AG plans legal changes that may pave the way for an initial public offering, indicating the 177-year-old company’s owner is relaxing its opposition to a share sale under new Chief Executive Officer Thomas Rabe.
-
Former Arcandor AG Chief Executive Officer Thomas Middelhoff ’s home and office were searched yesterday as part of a probe into the company’s bankruptcy.
-
Bochum prosecutors are looking into a 2.3 million-euro ($3.1 million) bonus payment former Arcandor AG Chief Executive Officer Thomas Middelhoff received before he left the company and six months before it filed for bankruptcy.
-
Thomas Middelhoff , the former chief executive officer of Arcandor AG, said any complaints made against him regarding the bankruptcy of the company are “completely groundless and absurd,” Frankfurter Allgemeine Sonntagszeitung reported, citing an interview with Middelhoff.
-
German insolvency administrator Klaus Hubert Goerg filed a second suit for exaggerated business expenses and too high bonuses against Thomas Middelhoff , the former chief executive officer of bankrupt retailer Arcandor AG , Financial Times Deutschland reported today, citing an unidentified Goerg spokesman.
-
A U.S. judge granted JPMorgan Chase & Co. ’s request to decide whether the trustee liquidating Bernard Madoff’s firm has the right to sue the bank for $6.4 billion, alleging it aided the confidence man’s fraud.
-
The supervisory board of Marseille- Kliniken AG appointed Thomas Middelhoff as its new chairman after Uwe Bergheim resigned.
-
Bochum prosecutors are looking into a 2.3 million-euro ($3.1 million) bonus payment former Arcandor AG Chief Executive Officer Thomas Middelhoff received before he left the company and six months before it filed for bankruptcy.
-
R. Allen Stanford’s criminal trial on charges he led a $7 billion investment fraud was postponed indefinitely by a U.S. judge while the Texas financier receives care for a prescription-drug addiction.
|
|
Most Popular on Bloomberg
|
| |